Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Why BioNTech’s Stock Is Trading Lower Wednesday

BioNTech SE – ADR (NASDAQ: BNTX) shares are trading lower by 12.6% at $364 Wednesday morning after findings from a recent Mayo Clinic study showed competitor Moderna's COVID-19 vaccine could possibly be more effective a
byHenry Khederian
August 11, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

BioNTech SE – ADR (NASDAQ:BNTX) shares are trading lower by 12.6% at $364 Wednesday morning after findings from a recent Mayo Clinic study showed competitor Moderna’s COVID-19 vaccine could possibly be more effective against the Delta variant.

Before the market open Wednesday, Bryan Garnier analyst Olga Smolentseva upgraded BioNTech Wednesday from Neutral to Buy and announced a $451 price target.

HC Wainwright & Co. analyst Robert Burns maintained BioNTech with a Neutral and raised the price target from $194 to $330.

BioNTech has a 52-week high of $464 and a 52-week low of $54.10.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Bulls and Bears Of The Week: Tesla, Twitter, Apple, Microsoft, And Why Kevin O’Leary Won’t Stop Buying This Chip Stock

By Michael Cohen
October 8, 11:42 AM
Benzinga has examined the prospects for many investors' favorite stocks over the past week, here's a look at some of our top stories.  The S&P 500 ended the week up by 0.83%, while the Nasdaq Composite finished down by 0.06% and the Dow Industrials closed 1.53% higher for the week.

AAPL